Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$27.91
00.00%
Pre-Market: 5:26 PM EDT
Comments
Loading...
Alkermes (ALKS) Forecast
NewsEarningsAlkermes (ALKS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Good
Alkermes (NASDAQ:ALKS) Stock Quotes, Forecast and News Summary
Alkermes Stock (NASDAQ: ALKS) stock price, news, charts, stock research, profile.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Alkermes (ALKS) stock?
You can purchase shares of Alkermes (NASDAQ:ALKS) through any online brokerage.
Who are Alkermes (ALKS) competitors?
Other companies in Alkermes’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Ionis Pharmaceuticals (NASDAQ:IONS).
What is the forecast, or price target, for Alkermes (ALKS) stock?
Alkermes has a consensus price target of $34.00.
What is the current price for Alkermes (ALKS)?
The stock price for Alkermes (NASDAQ: ALKS) is $27.91 last updated November 20, 2024 at 5:26 PM EST.
Does Alkermes (ALKS) pay a dividend?
There are no upcoming dividends for Alkermes.
When is Alkermes (NASDAQ:ALKS) reporting earnings?
Alkermes’s Q4 earnings are confirmed for Thursday, February 13, 2025.
Is Alkermes (ALKS) going to split?
There is no upcoming split for Alkermes.
What sector and industry does Alkermes (ALKS) operate in?
Alkermes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.